AMGN - AMGEN INC
IEX Last Trade
261.22
-0.290 -0.111%
Share volume: 66,235
Last Updated: Fri 10 Jan 2025 08:29:53 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.49%
PREVIOUS CLOSE
CHG
CHG%
$261.51
-0.29
-0.11%
View ratios
Fiscal Date | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 | 2024-09-30 | |
---|---|---|---|---|---|---|---|---|
Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | |
Report Date | 2024-05-02 | 2023-08-03 | 2023-10-31 | 2024-10-30 | 2024-05-02 | 2024-08-06 | 2024-10-30 | |
Total revenue | 6.105 B | 6.986 B | 6.903 B | 8.196 B | 7.447 B | 8.388 B | 8.503 B | |
Cost of revenue | 1.720 B | 1.813 B | 1.806 B | 3.112 B | 3.200 B | 3.236 B | 3.310 B | |
Gross profit | 4.385 B | 5.173 B | 5.097 B | 5.084 B | 4.247 B | 5.152 B | 5.193 B | |
17.97% | -1.47% | -0.26% | -16.46% | 21.31% | 0.80% | |||
Operating expenses | 2.316 B | 2.407 B | 2.432 B | 4.687 B | 3.151 B | 3.232 B | 3.075 B | |
Selling general and admin | 1.258 B | 1.294 B | 1.353 B | 3.153 B | 1.808 B | 1.785 B | 1.625 B | |
Research and development | 1.058 B | 1.113 B | 1.079 B | 1.534 B | 1.343 B | 1.447 B | 1.450 B | |
Total expenses | 2.464 B | 2.489 B | 3.076 B | 3.813 B | 3.256 B | 3.243 B | 3.146 B | |
1.01% | 23.58% | 23.96% | -14.61% | -0.40% | -2.99% | |||
Operating income | 1.921 B | 2.684 B | 2.021 B | 1.271 B | 991.000 M | 1.909 B | 2.047 B | |
Ebit | 3.985 B | 2.366 B | 2.706 B | 1.673 B | 756.000 M | 1.602 B | 3.877 B | |
Pretax income | 3.442 B | 1.614 B | 1.947 B | 852.000 M | -68.000 M | 794.000 M | 3.101 B | |
-53.11% | 20.63% | -56.24% | -107.98% | -1,267.65% | 290.55% | |||
Income tax | 601.000 M | 235.000 M | 217.000 M | 85.000 M | 45.000 M | 48.000 M | 271.000 M | |
Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Net income | 2.841 B | 1.379 B | 1.730 B | 767.000 M | -113.000 M | 746.000 M | 2.830 B | |
-51.46% | 25.45% | -55.66% | -114.73% | 760.18% | 279.36% |